Total investments received (USD): 23.75m
Round value (USD): 8.19m
Company: Exeliom Biosciences
Industry:
Biotech
Health services




Belgium
Austria
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
Spain